Subtype Selective Targeting
Subtype Selective Targeting - Related Videos
06:42
Subtype-selective Electroporation of Cortical Interneurons
0 Views •
Cited by 13 •
2014
This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.
01:23
Ethics in Target Audience Selection
0 Views •
2024
Ethics in targeting audiences is a crucial aspect of marketing and business practices. It involves understanding and respecting the rights, interests, and dignity of consumers while conducting any promotional activities or communications. Unethical targeting can lead to exploitation, manipulation, or harm, particularly for vulnerable groups like children, older people, or those with low financial literacy. Ethical targeting respects consumer privacy, avoids intrusive advertising, and ensures...
05:22
Using Phage Display to Select Proteins with High Affinity to a Target Protein
0 Views •
2025
In this video, we demonstrate the phage display technique to isolate pre-engineered phages expressing proteins with high affinity to the target protein.
14:40
Expression Analysis of Mammalian Linker-histone Subtypes
0 Views •
Cited by 22 •
2012
We describe a set of assays to analyze expression levels of H1 linker histones. mRNA of individual H1 genes are quantitatively measured by random primer based reverse transcription followed by real-time PCR, whereas protein quantification of H1 histones is achieved by HPLC analysis.
04:25
Simultaneous Eye Tracking and Single-Neuron Recording to Identify Target-Selective Neurons
0 Views •
2025
The video demonstrates an assay to identify target-selective neurons via simultaneous eye-tracking and single-neuron recordings. A human participant is tasked with identifying a target object among an array of objects in a display, and the eye movement is tracked. Simultaneously, single neurons' firing rate is recorded via electrodes implanted in the brain. The data from both recordings are correlated to assess the presence of target-selective neurons.
FAQs
Small structural differences within the binding sites of related receptors, ion channels, enzymes, or signaling proteins can determine whether a drug or probe interacts preferentially with one subtype. Exploiting these differences helps separate the intended molecular effect from activity at closely related targets. In neuroscience, that distinction can reveal which subtype contributes to a particular neural function or disease-related process.
A subtype’s cellular distribution provides an additional source of selectivity beyond binding-site structure. If related subtypes occur in different neural cells or pathways, an intervention directed toward one can influence a more specific circuit context. This information helps connect molecular activity with functions such as sensation, movement, or cognition and can clarify why similar targets produce different neurological effects.
Related molecular subtypes may trigger different downstream signaling even when they belong to the same family. Measuring or interpreting these signaling differences can show whether an intervention produces the intended functional response rather than merely binding to a related target. This distinction is important for assigning a neural effect to one subtype and for designing interventions with more precise outcomes.
A useful evaluation begins by identifying differences among related subtypes, including binding-site structure, cellular distribution, and downstream signaling. Researchers then examine whether a drug, probe, or genetic intervention preferentially affects the intended subtype and compare activity at related targets. The resulting pattern helps determine whether observed neural changes reflect genuine subtype selectivity rather than broader family-level modulation.
Selective modulation can isolate the contribution of one molecular subtype within a complex neural pathway. By preferentially altering that subtype, researchers can examine resulting changes in sensation, movement, cognition, or disease-related activity without treating every related target as equivalent. This makes the approach valuable for linking a molecular component to a specific neural function or pathological process.
Researchers may use subtype-selective drugs, probes, or genetic interventions when they need to distinguish the roles of closely related molecular targets. The approach can help map subtype contributions to neural circuits, interpret downstream effects, and investigate mechanisms of neurological disease. Its value lies in producing more discriminating experimental evidence than interventions that affect multiple related subtypes together.
Therapeutic development can use subtype selectivity to preserve intended activity while reducing effects on related targets. By focusing modulation on a molecular subtype associated with a desired neural pathway, developers may improve therapeutic precision and limit off-target activity. In neuroscience, this strategy is relevant to reducing adverse neurological outcomes while retaining effects connected with sensation, movement, cognition, or disease.